Comparison of the Effects of Nasal Steroids and Montelukast on Olfactory Functions in Patients With Allergic Rhinitis
Primary Purpose
Allergic Rhinitis
Status
Completed
Phase
Phase 4
Locations
Study Type
Interventional
Intervention
Montelukast,mometazon froat
Sponsored by
About this trial
This is an interventional treatment trial for Allergic Rhinitis focused on measuring Montelukast, Sniffin' Sticks test, allergic rhinitis, mometasone furoate
Eligibility Criteria
Inclusion Criteria:
- Positive skin test to grass and/or tree pollens in patients with clinical history of seasonal AR for at least 1 year
Exclusion Criteria:
- Patients who had received drug treatment or immunotherapy before the study were excluded.
- Patients with asthma, deviated nasal septum, history of nasal operation, turbinate hypertrophy, nasal polyposis or chronic nasal disorders, pregnancy, or upper airway infections were also excluded.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Active Comparator
Active Comparator
Arm Label
GROUP 1
Group 2
Group 3
Arm Description
montelukast sodium and mometasone
montelukast
mometasone furoate
Outcomes
Primary Outcome Measures
Comparison of the effects of nasal steroids and montelukast on olfactory functions in patients with allergic rhinitis
Sniff'in and Snick test (olfactory Test)
Secondary Outcome Measures
Full Information
NCT ID
NCT02565212
First Posted
June 15, 2015
Last Updated
September 29, 2015
Sponsor
Istanbul Training and Research Hospital
1. Study Identification
Unique Protocol Identification Number
NCT02565212
Brief Title
Comparison of the Effects of Nasal Steroids and Montelukast on Olfactory Functions in Patients With Allergic Rhinitis
Official Title
Istanbul Gaziosmanpasa Taksim Research and Training Hospital,
Study Type
Interventional
2. Study Status
Record Verification Date
September 2015
Overall Recruitment Status
Completed
Study Start Date
May 2014 (undefined)
Primary Completion Date
October 2014 (Actual)
Study Completion Date
October 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Istanbul Training and Research Hospital
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The investigators aimed to evaluate by the Sniffin' Sticks test the effects on olfactory functions of nasal steroids and leukotriene antagonists used for allergic rhinitis.Thirty patients with seasonal were included in this study. Patients were randomly divided into three groups of 10 patients; group 1 received montelukast sodium and mometasone furoate therapy, group 2 received only montelukast, and group 3 only mometasone furoate. Patients' olfactory functions were determined using the Sniffin' Sticks olfactory test before and after a month treatments.
Threshold, discrimination, identification, and TDI values were not significantly different among the groups before treatment. For Group 1 and Group 3 patients, there were statistically significant differences in threshold, discrimination, identification, and TDI values before and after treatment (p < 0.05) (Wilcoxon signed ranks analysis) For Group 2 patients, the before and after treatment values of threshold, discrimination, identification, and TDI showed no significant differences (p > 0.05). According to the findings of our study, MF is superior to montelukast in improving olfactory function. Although montelukast has been shown to be effective against AR symptoms, its effect on olfactory function was not demonstrated in this study.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Allergic Rhinitis
Keywords
Montelukast, Sniffin' Sticks test, allergic rhinitis, mometasone furoate
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
30 (Actual)
8. Arms, Groups, and Interventions
Arm Title
GROUP 1
Arm Type
Experimental
Arm Description
montelukast sodium and mometasone
Arm Title
Group 2
Arm Type
Active Comparator
Arm Description
montelukast
Arm Title
Group 3
Arm Type
Active Comparator
Arm Description
mometasone furoate
Intervention Type
Drug
Intervention Name(s)
Montelukast,mometazon froat
Primary Outcome Measure Information:
Title
Comparison of the effects of nasal steroids and montelukast on olfactory functions in patients with allergic rhinitis
Description
Sniff'in and Snick test (olfactory Test)
Time Frame
1 month
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Positive skin test to grass and/or tree pollens in patients with clinical history of seasonal AR for at least 1 year
Exclusion Criteria:
Patients who had received drug treatment or immunotherapy before the study were excluded.
Patients with asthma, deviated nasal septum, history of nasal operation, turbinate hypertrophy, nasal polyposis or chronic nasal disorders, pregnancy, or upper airway infections were also excluded.
12. IPD Sharing Statement
Learn more about this trial
Comparison of the Effects of Nasal Steroids and Montelukast on Olfactory Functions in Patients With Allergic Rhinitis
We'll reach out to this number within 24 hrs